Gem-dichlorocyclopropanes as antitumor agents
AssigneeResearch Corporation Technologies, Inc.
InventorsRobert A. Magarian, Joseph T. Pento, May T. Griffin
Life of this patent
Estimating the term…
Loading patent…
AssigneeResearch Corporation Technologies, Inc.
InventorsRobert A. Magarian, Joseph T. Pento, May T. Griffin
Estimating the term…
Gem-Dichlorocyclopropanes (Analog II derivatives) which demonstrate antiproliferative activity toward MCF-7 cells, in vitro and are generally not reversed by estradiol or having intrinsic estrogenicity (except the hydroxyphenyl derivative Compound 30). In general the cyclopropane compounds have the formula: ##STR1## or any pharmaceutically acceptable salt thereof. X is selected from a group consisting of hydrogen and halogen atoms. The group R.sub.1 may be a hydrogen atom, an alkyl group, an acyl group, or an arylalkyl group. The group R.sub.2 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The group R.sub.3 may be a hydrogen atom, an alkyl group, a cycloalkyl group, a substituted aryl group or an unsubstituted aryl group. The group R.sub.4 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The R.sub.4 is absent when R.sub.3 is a cycloalkyl group having a first position carbon and a terminal position carbon bonded to the same carbon of the cyclopropane. Further, no more than any two of R.sub.2, R.sub.3 and R.sub.4 has an aryl group.
A cyclopropane compound having the formula:
A composition of matter comprising a compound having the formula:
A method of increasing uterine growth in a mammal comprising administering to the mammal an effective amount of one or more of the compounds having the formula:
Dependencies are inferred from the claim text.